Personalized Medicine
320 articles
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
“Radical Collaboration” to Find Cures for the Deadliest Cancers
Break Through Cancer was founded to promote collaboration between major research institutions, in order to develop cures for the deadliest cancers.
Working with Oncologists Willing to Take Risks
Anne Glauber chooses the new science of slow dosing of chemotherapy for her pancreatic treatment. She looks to developing science for future treatments.
Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Stephen Bigelsen was diagnosed with stage IV pancreatic cancer, he found a doctor to created a personalized treatment plan.
Fighting On To See Her Children Grow Up
Despite aggressive pancreatic cancer, with a BRCA-like genetic mutation, Dr. Jill Pechacek is determined to stay alive to see her children grow up.
Finding Qualified Doctors Made All the Difference
Lee Ringuette switched doctors to get ones willing to try new treatment protocols so he could have to a Whipple procedure.
Going Outside Standard Protocol Changed Everything
Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
Meet the Researcher: Hiroyuki Kato, M.D., Ph.D.
Researcher Dr. Hiroyuki Kato has traveled from Japan to Boston for his research on IPMNs and pancreatic cancer.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
Testing the Safety of an Immunotherapy Combination After Surgery
A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.
mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.
mRNA Vaccine Shows Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran reports notable antitumor response in about half to the patients in his mRNA vaccine clinical trial.
